Trials / Completed
CompletedNCT04035161
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
Evaluation of the Antimicrobial Effectiveness of CHG/IPA in Healthy Volunteers
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 1,935 (actual)
- Sponsor
- Becton, Dickinson and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This single site study is a randomized, controlled, partially-blinded design enrolling a minimum of 516 healthy volunteers, where each subject will receive two of the planned study products on the product application sites of the abdomen and/or groin.
Detailed description
To demonstrate the antimicrobial activity of the Investigational Product (IP) by comparing counts of resident skin microbes, obtained after IP application to intact skin of the abdomen and groin, to counts obtained prior to application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Investigational Product | 2%(w/v) Chlorhexidine in 70%(v/v) Isopropyl skin preparation |
| OTHER | Reference Standard | 60% (v/v) 1-propanol skin preparation |
| COMBINATION_PRODUCT | Active Comparator | ChloraPrep® SEPP® skin preparation |
| OTHER | Negative Control | 0.9% Normal Saline skin preparation |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2019-12-24
- Completion
- 2019-12-24
- First posted
- 2019-07-29
- Last updated
- 2021-08-17
- Results posted
- 2021-08-17
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04035161. Inclusion in this directory is not an endorsement.